Literature DB >> 804483

Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

D C Morrison, L Leive.   

Abstract

Lipopolysaccharides have been extracted from Escherichia coli O111:B4 by phenol extraction and by a new method employing aqueous butanol. Both methods yield very similar lipopolysaccharide preparations. Gel filtration chromatography of either preparation yields two physically and chemically distinct lipopolysaccharide fractions. One fraction contains lipopolysaccharide molecules with long antigenic side chains. It acts like a highly asymmetric unit with an apparent weight of 1.5 times 10-6 and is not dissociated by detergents or deacylation. The second fraction has a short antigenic side chain and can be dissociated by sodium dodecyl sulfate and Triton X-100 into units of approximately 90,000. Some properties of the lipopolysaccharide fractions vary with the method of extraction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 804483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  120 in total

1.  Distribution and kinetics of lipoprotein-bound endotoxin.

Authors:  J H Levels; P R Abraham; A van den Ende; S J van Deventer
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  VimA-dependent modulation of acetyl coenzyme A levels and lipid A biosynthesis can alter virulence in Porphyromonas gingivalis.

Authors:  A Wilson Aruni; J Lee; D Osbourne; Y Dou; F Roy; A Muthiah; D S Boskovic; H M Fletcher
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Lipopolysaccharide-induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae.

Authors:  U C Chathley; S Sharma; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

Review 4.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

5.  Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populations.

Authors:  J L Halling; D R Hamill; M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Paclitaxel (Taxol)-induced killing of Leishmania major in murine macrophages.

Authors:  T M Doherty; A Sher; S N Vogel
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Evidence that lipopolysaccharide and pertussis toxin bind to different domains on the same p73 receptor on murine splenocytes.

Authors:  M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Susceptibility of lipopolysaccharide mutants to the bactericidal action of human neutrophil lysosomal fractions.

Authors:  R F Rest; M H Cooney; J K Spitznagel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.

Authors:  R K Gupta; W Egan; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Lipopolysaccharide priming of superoxide release by human neutrophils: role of membrane CD14 and serum LPS binding protein.

Authors:  L Shapira; C Champagne; B Gordon; S Amar; T E Van Dyke
Journal:  Inflammation       Date:  1995-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.